fxr molecular target effects vertical sleeve gastrectomy
bariatric surgical procedures vertical sleeve gastrectomy vsg present effective therapy treatment obesity associated considerable improvements co-morbidities including type diabetes mellitus underlying molecular mechanisms contributing benefits remain largely undetermined despite offering potential reveal new targets therapeutic intervention substantial changes circulating total bile acids known occur vsg moreover bile acids known regulate metabolism binding nuclear receptor fxr farsenoid-x receptor also known nr1h4 therefore examined results vsg surgery applied mice diet-induced obesity targeted genetic disruption fxr demonstrate therapeutic value vsg result mechanical restriction imposed smaller stomach rather vsg associated increased circulating bile acids associated changes gut microbial communities moreover absence fxr ability vsg reduce body weight improve glucose tolerance substantially reduced results point bile acids fxr signalling important molecular underpinning beneficial effects weight-loss surgery
